Please Find Attached Postal Ballot Notice of Supriya Lifescience Limited.

July 21, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001. Bandra (E), Mumbai - 400 051. Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Intimation of Notice of Postal Ballot Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a copy of the Notice of Postal Ballot dated May 22, 2026, along with the explanatory statement pursuant to Section 102 of the Companies Act, 2013 (Notice’) of Supriya Lifescience Limited (‘the Company’) seeking approval of the Members of the Company on the following resolution, through postal ballot: - Sr. Particulars Resolution No. Type 1. Re-appointment of Mr. Balasaheb Sawant (DIN: 07743507) as Whole Time Director and Special Key Managerial Personnel of the Company for a term of three (3) consecutive years from May 26, 2026, to May 25, 2029. In accordance with various Circulars issued by Ministry of Corporate Affairs, from time to time, the Postal Ballot Notice indicating, inter alia, the process and manner of remote e-voting, is being sent only through electronic mode to the members whose names appear on the Register of Members / List of Beneficial Owners as on Friday, July 17, 2026 (‘cut-off date’) received from the Depositories and whose e-mail address are registered with the Company/ Registrar and Transfer Agent (‘RTA’)/ Depositories. Members are required to communicate their assent or dissent through the remote e-voting system only. In compliance with Regulation 44 of the SEBI Listing Regulations and pursuant to the provisions of Section 108 and Section 110 of the Act read with the Rules, the Company has engaged the services of National Securities Depository Limited (NSDL’) for the purpose of providing remote e-voting facility to its Members. The instructions for remote e- voting are appended to this Notice. The Notice is also available on the website of the Company www.supriyalifescience.com and on the website of NSDL at www.evoting.nsdl.com. The remote e-voting period commences on Thursday, July 23, 2026, at 9.00 a.m. IST and ends on Friday, August 21, 2026, at 5.00 p.m. IST. Request you to kindly take the same on record. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LIMITED CIN: L51900MH2008PLC180452 Registered Office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400063, India. E-mail ID: cs@supriyalifescience.com; Tel: +91 22 40332727; Website: www.supriyalifescience.com ; NOTICE OF POSTAL BALLOT [Pursuant to Section 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, each as amended.] Voting Starts on Voting Ends on Thursday, July 23, 2026, at 9.00 a.m. IST Friday, August 21, 2026, at 5.00 p.m. IST Dear Member(s), NOTICE is hereby given pursuant to Section 110 read with Section 108 and other applicable provisions, if any, of the Companies Act, 2013, (‘Act’) (including any statutory modification or re-enactment thereof for the time being in force), read with Rule 20 and 22 of the Companies (Management and Administration) Rules, 2014, (‘Rules’), Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) and the Secretarial Standard on General Meetings issued by The Institute of Company Secretaries of India (‘SS-2’), read with General Circular No.14/2020 dated 8th April, 2020, General Circular No.17/2020 dated 13th April, 2020, General Circular No.11/2022 dated 28th December, 2022, General Circular No.9/2023 dated 25th September, 2023, Circular No. 09/2023 dated September 19, 2024 and General Circular No.03/2025 dated September 22, 2025 issued by the Ministry of Corporate Affairs, Government of India (hereinafter collectively referred to as ‘MCA Circulars’) and all/or any other applicable law, rules or regulations for the time being in force, to transact the special business as set out hereunder by passing Special Resolution, as applicable, by way of postal ballot / electronic voting. Pursuant to Section 102 and Section 110 and other applicable provisions of the Act, the Explanatory Statement pertaining to the said Resolution setting out the material facts and the reasons/ rationale thereof are annexed to this Postal Ballot Notice (Notice’) for your consideration and forms part of this Notice. Supriya Lifescience Limited (the “Company”) is sending this Notice in electronic form to those Members whose e-mail addresses are registered with the Company/ Registrar and Transfer Agent (‘RTA’) / Depositories. Accordingly, physical copy of the Notice along with Postal Ballot Form and pre-paid business reply envelope are not being sent to the Members for this Postal Ballot. The communication of the assent or dissent of the Members would take place through the remote e-voting system. The details of the procedure to cast the vote forms part of the ‘Notes’ to this Notice. In compliance with Regulation 44 of the SEBI Listing Regulations and pursuant to the provisions of Section 108 and Section 110 of the Act read with the Rules, the Company has engaged services of National Securities Depository Limited (NSDL’) for the purpose of providing remote e-voting facility to its Members. The instructions for remote e-voting are appended to this Notice. The Board of Directors of the Company have appointed CS Sanam Umbargikar (FCS 11777), Partner of M/s. DSM & Associates, Company Secretaries, (hereinafter referred to as the “Practicing Company Secretary” or “PCS”) as the Scrutinizer for conducting the e-voting process in a fair and transparent manner. Members have to vote through e-voting. Members desiring to opt for e-voting as per the facilities arranged by the Company are requested to read the instructions in the ‘Notes’. References to postal ballot(s) in this Postal Ballot Notice include votes received electronically. The Scrutinizer will submit his report to the Chairman of the Company, or any other person duly authorized by him, after completion of scrutiny of the postal ballots (including e-voting). The results shall be declared on or Friday, August 22, 2026, 2026, at Registered Office of the Company at 207/208, Udyog Bhawan, Sonawala Road, Goregaon (East), Mumbai –400 063, Maharashtra, India. The voting results along with the Scrutinizer’s Report shall also be intimated to the National Stock Exchange of India Limited (‘NSE’) and BSE Limited (‘BSE’) (hereinafter collectively referred to as ‘Stock Exchanges’) where the Equity Shares of the Company are listed and will also be displayed on the notice board of the Company and the Company’s website at www.supriyalifescience.com as well as on the website of NSDL at www.evoting.nsdl.com. The last date for e-Voting i.e. Friday, August 21, 2026, shall be deemed to be the effective date of passing of the Resolutions as per SS-2. SPECIAL BUSINESS: 1. RE-APPOINTMENT OF MR. BALASAHEB SAWANT (DIN: 07743507) AS WHOLE TIME DIRECTOR AND KEY MANAGERIAL PERSONNEL OF THE COMPANY FOR A TERM OF THREE (3) CONSECUTIVE YEARS FROM MAY 26, 2026, TO MAY 25, 2029. To consider and, if thought fit, to pass the following Resolution as a Special Resolution: “RESOVLED THAT pursuant to the provisions Sections 196, 197, 198 and 203 and all other appl [Showing first 8,000 characters — download PDF for full document]